Notes
Reactions Weekly is the complete drug safety alerting service and summarizes information selected from over 1800 biomedical journals. This newsletter is produced by Adis International and is available in a variety of formats. Please contact your nearest Adis office (see inside back cover) for subscription details.
References
Halevi A., Ben-Amitai D., Garty B.Z. Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000 Jan; 34: 32–34
Schissel D.J., Singer D., David-Bajar K. Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis 2000 Mar; 65: 163–166
Leyva L., Torres M.J., Posadas S., et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol 2000 Jan; 105 (1): 157–165
Crouch T.E., Stafford C.T. Urticaria associated with COX-2 inhibitors [abstract]. Annals of Allergy Asthma Immunol 2000 Jan; 84: 140
Mu~noz-Bellido F.J., Beltr’an A., Bellido J. Contact urticaria due to cyclopentolate hydrochloride. Allergy 2000 Feb; 55: 198–199
Saenz de San Pedro B., Quiralte J., Florido J.F. Fixed drug eruption caused by dimenhydrinate. Allergy 2000 Mar; 55: 297
Cleveland M.G., Ajaikumar B.S., Reganti R. Cutaneous fibrosis induced by docetaxel. Cancer 2000 Mar 1; 88: 1078–1081
Aubin F., Cahn J.Y., Ferrand C., et al. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet 2000 Feb 19; 355: 626–627
Flores F., Eaglstein W.A., Krisner R.S. Hydroxyurea-induced leg ulcers treated with Apligraf. Ann Intern Med 2000 Mar 7; 132: 417–418
Pföhler C., Ugurel S., Seiter S., et al. Interferon-alpha-associated development of bullous lesions in mycosis fungoides. Dermatology 2000; 200 (1): 51–53
Finch T.M., Muncaster A., Prais L., et al. Occupational airborne allergic contact dermatitis from isoflurane vapour. Contact Dermatitis 2000 Jan; 42: 46
Bong J.L., Lucke T.W., Douglas W.S. Lichenoid drug eruption with proton pump inhibitors. BMJ 2000 Jan 29; 320: 283
Tanzi E.L., Hecker M.S. Minocycline-induced hyperpigmentation of the tongue. Arch Dermatol 2000 Mar; 136: 427–428
Semhoun-Ducloux S., Ducloux D., Miguet J.-P. Mycophenolate mofetil-induced dyshidrotic eczema. Ann Intern Med 2000 Mar 7; 132: 417
Almagro M., Del Pozo J., Garcia-Silva J., et al. Nail alterations secondary to paclitaxel therapy. Eur J Dermatol 2000 Mar; 10: 146–147
V’elez A, Moreno J-C. Second case of ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura. J Am Acad Dermatol 200 Feb; 42 (Pt 1): 305
Shimizu H., Ueda M., Takai T., et al. A case of serratiopeptidase-induced subepidermal bullous dermatosis. Br J Dermatol 1999 Dec; 141: 1139–1140
Seishima M., Izumi T., Kanoh H. Raynaud’s phenomenon possibly induced by a compound drug of tegafur and uracil. Eur J Dermatol 2000 Jan–Feb; 10: 55–58
Kono T., Ishii M., Negoro N., Taniguchi S. Scleroderma-like reaction induced by uraciltegafur (UFT), a second-generation anticancer agent. J Am Acad Dermatol 2000 Mar; 42: 519–520
Hall A.P., Tate B. Acute generalized exanthematous pustulosis associated with oral terbinafine. Australas J Dermatol 2000 Feb; 41: 42–45
Cannavò S.P., Borgia F., Guarneri F., et al. Acute generalized exanthematous pustulosis following use of ticlopidine. Br J Dermatol 2000; 142: 577–578
Bedard K., Smith S., Cribb A. Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction. Br J Dermatol 2000 Feb; 142: 253–258
García Muret M.P., Ferrer J., Fernandez Figueras M.T., Perez M. Psoriasiform eruption induced by venlafaxine [abstract]. 58th Annual Meeting American Academy of Dermatology: 2000 Mar 10: 178
Rights and permissions
About this article
Cite this article
Drug Reaction Case Reports. Am J Clin Dermatol 1, 253–260 (2000). https://doi.org/10.2165/00128071-200001040-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200001040-00009